These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20140016)

  • 21. PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.
    Hu XF; Li J; Vandervalk S; Wang Z; Magnuson NS; Xing PX
    J Clin Invest; 2009 Feb; 119(2):362-75. PubMed ID: 19147983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.
    Nandana S; Ellwood-Yen K; Sawyers C; Wills M; Weidow B; Case T; Vasioukhin V; Matusik R
    Prostate; 2010 May; 70(6):591-600. PubMed ID: 19938013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways.
    Santio NM; Salmela M; Arola H; Eerola SK; Heino J; Rainio EM; Koskinen PJ
    Exp Cell Res; 2016 Mar; 342(2):113-24. PubMed ID: 26934497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.
    Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M
    Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing T(H)2 and T(H)17 T-cell differentiation.
    Wang M; Okamoto M; Domenico J; Han J; Ashino S; Shin YS; Gelfand EW
    J Allergy Clin Immunol; 2012 Oct; 130(4):932-44.e12. PubMed ID: 22944483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
    Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
    Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis.
    Remy J; Linder B; Weirauch U; Konovalova J; Marschalek R; Aigner A; Kögel D
    Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):175-189. PubMed ID: 30389373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of PIM1/PIM2 kinases in tumors of the male reproductive system.
    Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Narlik-Grassow M; Blanco-Aparicio C; Carnero A
    Sci Rep; 2016 Nov; 6():38079. PubMed ID: 27901106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of quinones as novel PIM1 kinase inhibitors.
    Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
    Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
    Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
    Torres-Ayuso P; Katerji M; Mehlich D; Lookingbill SA; Sabbasani VR; Liou H; Casillas AL; Chauhan SS; Serwa R; Rubin MR; Marusiak AA; Swenson RE; Warfel NA; Brognard J
    Cell Chem Biol; 2024 Feb; 31(2):326-337.e11. PubMed ID: 38016478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer.
    Chauhan SS; Casillas AL; Vizzerra AD; Liou H; Clements AN; Flores CE; Prevost CT; Kashatus DF; Snider AJ; Snider JM; Warfel NA
    Oncogene; 2024 Feb; 43(6):406-419. PubMed ID: 38097734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
    Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins.
    Santio NM; Vainio V; Hoikkala T; Mung KL; Lång M; Vahakoski R; Zdrojewska J; Coffey ET; Kremneva E; Rainio EM; Koskinen PJ
    Cell Commun Signal; 2020 Aug; 18(1):121. PubMed ID: 32771000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.
    Motylewska E; Braun M; Stępień H
    Endocr Pathol; 2020 Sep; 31(3):264-273. PubMed ID: 32504181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
    Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
    Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pim family kinases enhance tumor growth of prostate cancer cells.
    Chen WW; Chan DC; Donald C; Lilly MB; Kraft AS
    Mol Cancer Res; 2005 Aug; 3(8):443-51. PubMed ID: 16123140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and ERG regulation of PIM kinases in prostate cancer.
    Eerola SK; Kohvakka A; Tammela TLJ; Koskinen PJ; Latonen L; Visakorpi T
    Cancer Med; 2021 May; 10(10):3427-3436. PubMed ID: 33932111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc-driven murine prostate cancer shares molecular features with human prostate tumors.
    Ellwood-Yen K; Graeber TG; Wongvipat J; Iruela-Arispe ML; Zhang J; Matusik R; Thomas GV; Sawyers CL
    Cancer Cell; 2003 Sep; 4(3):223-38. PubMed ID: 14522256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.